Spots Global Cancer Trial Database for rosuvastatin
Every month we try and update this database with for rosuvastatin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis | NCT05741372 | Liver Cirrhosis | Rosuvastatin Digoxin Metformin hydro... Furosemide | 18 Years - 75 Years | Boehringer Ingelheim | |
| Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors | NCT03864042 | Advanced Solid ... Metastatic Mela... | losartan dextromethorpha... caffeine omeprazole midazolam rosuvastatin bupropion immed... encorafenib binimetinib modafinil | 18 Years - | Pfizer | |
| Drug-Drug Interaction Study of Rucaparib, Rosuvastatin and Oral Contraceptives | NCT03954366 | Neoplasms | Rucaparib Rosuvastatin Oral Contracept... | 18 Years - | pharmaand GmbH | |
| Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects | NCT06348290 | Solid Tumor, Ad... | JMKX001899 Itraconazole Midazolam Rifampin dextromethorpha... Rosuvastatin digoxin | 18 Years - 45 Years | Jemincare | |
| A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer | NCT04094519 | Prostate Cancer | enzalutamide enzalutamide Pl... digoxin rosuvastatin | 18 Years - | Astellas Pharma Inc | |
| Effect of Coadministration of Sotorasib on the Pharmacokinetics of Rosuvastatin in Healthy Participants | NCT05045638 | Healthy Partici... | Rosuvastatin Sotorasib | 18 Years - 60 Years | Amgen | |
| Effects of Dabrafenib on the Single Dose Pharmacokinetics (PK) of Rosuvastatin and Midazolam | NCT02082665 | Cancer | Rosuvastatin10 ... Midazolam 3 mg ... Dabrafenib 75 m... | 18 Years - 65 Years | GlaxoSmithKline | |
| Fruquintinib DDI Study With P-gp and BCRP Substrates | NCT05368805 | Metastatic Colo... | Fruquintinib Dabigatran Etex... Rosuvastatin | 18 Years - 55 Years | Hutchmed | |
| Effect of Regorafenib on Digoxin and Rosuvastatin in Patients With Advanced Solid Malignant Tumors. | NCT02106845 | Neoplasms | Digoxin Rosuvastatin Regorafenib (St... | 18 Years - | Bayer | |
| Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects | NCT06348290 | Solid Tumor, Ad... | JMKX001899 Itraconazole Midazolam Rifampin dextromethorpha... Rosuvastatin digoxin | 18 Years - 45 Years | Jemincare | |
| A Pharmacokinetic Interaction Study Between Apatinib and Rosuvastatin or Metformin in Solid Tumor Subjects. | NCT04428086 | Solid Tumor, Ad... | Apatinib in arm... Rosuvastatin Apatinib in arm... Metformin | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| Study to Learn the Effect of Drug BAY1817080 on the Way the Body Absorbs, Distributes and Excretes Another Drug Rosuvastatin in Healthy Adult Participants | NCT04252300 | Drug Interactio... | Rosuvastatin Rosuvastatin + ... | 18 Years - 55 Years | Bayer | |
| Rosuvastatin in the Treatment of Rectal Cancer | NCT02569645 | Rectal Cancer | Rosuvastatin | 18 Years - | AHS Cancer Control Alberta | |
| Identification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP) | NCT04542382 | Healthy Volunte... | Rosuvastatin Rosuvastatin (I... Eltrombopag | 18 Years - 64 Years | University of California, San Francisco | |
| A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer | NCT04094519 | Prostate Cancer | enzalutamide enzalutamide Pl... digoxin rosuvastatin | 18 Years - | Astellas Pharma Inc | |
| Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer | NCT01299038 | Breast Cancer | rosuvastatin | 18 Years - | Dana-Farber Cancer Institute | |
| Potential Drug Interaction Between ALXN2040 and Rosuvastatin | NCT05708573 | Healthy Partici... | Rosuvastatin ALXN2040 | 18 Years - 55 Years | Alexion Pharmaceuticals, Inc. | |
| A Pharmacokinetic Interaction Study Between Apatinib and Rosuvastatin or Metformin in Solid Tumor Subjects. | NCT04428086 | Solid Tumor, Ad... | Apatinib in arm... Rosuvastatin Apatinib in arm... Metformin | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer | NCT01051401 | Cardiovascular ... Recurrent Breas... Stage I Breast ... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | rosuvastatin placebo survey administ... management of t... | - | Wake Forest University Health Sciences | |
| Drug-drug Interaction Study Using Rosuvastatin as a Breast Cancer Resistant Protein (Efflux Transporter), Organic Anion-transporting Polypeptide (OATP)1B1, and OATP1B3 (Uptake Transporters) Probe Substrate | NCT02671097 | Healthy Volunte... Pharmacokinetic... Drug Interactio... | Rosuvastatin BAY1841788 (ODM... | 45 Years - 65 Years | Bayer | |
| Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer | NCT01051401 | Cardiovascular ... Recurrent Breas... Stage I Breast ... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | rosuvastatin placebo survey administ... management of t... | - | Wake Forest University Health Sciences | |
| Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy | NCT02483871 | Breast Cancer | Rosuvastatin | - | Duke University | |
| A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer | NCT02592317 | Prostatic Neopl... | JNJ 56021927 Drug Cocktail Pioglitazone Rosuvastatin | 18 Years - | Aragon Pharmaceuticals, Inc. | |
| Effect of Coadministration of Sotorasib on the Pharmacokinetics of Rosuvastatin in Healthy Participants | NCT05045638 | Healthy Partici... | Rosuvastatin Sotorasib | 18 Years - 60 Years | Amgen | |
| Drug-Drug Interaction Study of Rucaparib, Rosuvastatin and Oral Contraceptives | NCT03954366 | Neoplasms | Rucaparib Rosuvastatin Oral Contracept... | 18 Years - | pharmaand GmbH | |
| Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer | NCT01051401 | Cardiovascular ... Recurrent Breas... Stage I Breast ... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... | rosuvastatin placebo survey administ... management of t... | - | Wake Forest University Health Sciences | |
| Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS) | NCT05483010 | Clonal Cytopeni... Myelodysplastic... | Atorvastatin Rosuvastatin | 18 Years - | Washington University School of Medicine | |
| PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates | NCT04887194 | Advanced Solid ... | Sitravatinib Warfarin Dextromethorpha... Midazolam Digoxin Rosuvastatin Nivolumab | 18 Years - | Mirati Therapeutics Inc. | |
| Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS) | NCT05483010 | Clonal Cytopeni... Myelodysplastic... | Atorvastatin Rosuvastatin | 18 Years - | Washington University School of Medicine | |
| A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer | NCT02592317 | Prostatic Neopl... | JNJ 56021927 Drug Cocktail Pioglitazone Rosuvastatin | 18 Years - | Aragon Pharmaceuticals, Inc. | |
| A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis | NCT05741372 | Liver Cirrhosis | Rosuvastatin Digoxin Metformin hydro... Furosemide | 18 Years - 75 Years | Boehringer Ingelheim | |
| Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery | NCT01011478 | Colorectal Canc... Precancerous Co... | rosuvastatin placebo | 18 Years - | NSABP Foundation Inc | |
| A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors | NCT02626234 | cMET-dysregulat... | INC280 digoxin rosuvastatin | 18 Years - | Novartis | |
| Effect of Coadministration of Sotorasib on the Pharmacokinetics of Rosuvastatin in Healthy Participants | NCT05045638 | Healthy Partici... | Rosuvastatin Sotorasib | 18 Years - 60 Years | Amgen | |
| Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer | NCT01299038 | Breast Cancer | rosuvastatin | 18 Years - | Dana-Farber Cancer Institute | |
| Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE) | NCT01524653 | Venous Thromboe... Deep Vein Throm... Neoplasms | Rosuvastatin Placebo | 18 Years - | University of Vermont |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
